a month ago
BNGO
AnalystsMark MassaroMark Massaro's Stock Forecasts
AnalystsMark Massaro
Analyst Ranking
Bottom 2%
#4257 out of 4334 analysts
Average Return
-11.15%
Win Rate
41%37 out of 91
Risk vs Reward
Poor
Good
Mark Massaro's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Castle Biosciences IncCSTL | +109.80% | $33.99 | $71.31 | 2019-12-27 - 2020-12-24 | Strong Buy |
Quidelortho CorpQDEL | +88.20% | $37.36 | $70.31 | 2017-07-18 - 2018-07-18 | Strong Buy |
Exact Sciences CorpEXAS | +87.79% | $52.02 | $97.69 | 2018-04-27 - 2019-04-26 | Strong Buy |
Genmark Diagnostics IncGNMK | +86.65% | $4.12 | $7.69 | 2018-02-28 - 2019-02-28 | Strong Buy |
Exact Sciences CorpEXAS | +82.21% | $38.16 | $69.53 | 2022-11-07 - 2023-09-21 | Strong Buy |
Mark Massaro Analyst Color
Get additional color on Mark Massaro's coverage of popular stocks
a year ago
MDXH
a year ago
DNA
a year ago
MXCT
Mark Massaro's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Talis Biomedical CorpTLIS | 3 | Strong Sell | $5.00 | -12.89% | Maintains | a month ago |
Bionano Genomics IncBNGO | 6 | Strong Buy | $10.00 | +235.57% | Maintains | a month ago |
Dermtech IncDMTK | 3 | Strong Buy | $5.00 | +194.12% | Maintains | a month ago |
Castle Biosciences IncCSTL | 2 | Strong Buy | $30.00 | +80.07% | Maintains | 3 months ago |
Mdxhealth SaMDXH | 7 | Strong Buy | $7.00 | +160.22% | Maintains | 4 months ago |
Cue Health IncHLTH | 4 | Strong Buy | $3.00 | +575.68% | Maintains | 4 months ago |
Neogenomics IncNEO | 2 | Strong Buy | $25.00 | +104.92% | Upgrades | 4 months ago |
Renalytix PLCRNLX | 3 | Strong Buy | $3.50 | +74.13% | Maintains | 6 months ago |
Exagen IncXGN | 3 | Strong Buy | $5.00 | +106.61% | Maintains | 6 months ago |
Caredx IncCDNA | 2 | Strong Buy | $25.00 | +222.58% | Maintains | 7 months ago |
Guardant Health IncGH | 1 | Strong Buy | $50.00 | +91.50% | Maintains | 7 months ago |
Exact Sciences CorpEXAS | 9 | Strong Buy | $80.00 | +15.06% | Maintains | 7 months ago |
Sophia Genetics SaSOPH | 1 | Strong Buy | $6.00 | +144.90% | Initiates Coverage On | 9 months ago |
Lucid Diagnostics IncLUCD | 2 | Strong Buy | $3.50 | +143.06% | Maintains | 10 months ago |
Lumiradx LtdLMDX | 1 | Strong Buy | $4.00 | N/A | Maintains | a year ago |
Genedx Holdings CorpWGS | 2 | Strong Buy | $3.00 | N/A | Maintains | a year ago |
Ginkgo Bioworks Holdings IncDNA | 2 | Strong Buy | $6.00 | N/A | Maintains | a year ago |
Maxcyte IncMXCT | 2 | Strong Buy | $11.00 | N/A | Maintains | a year ago |
Phenomex IncCELL | 2 | Hold | N/A | N/A | Downgrades | a year ago |
T2 Biosystems IncTTOO | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Quotient LtdQTNTQ | 1 | Strong Buy | $1.50 | N/A | Maintains | a year ago |
Akoya Biosciences IncAKYA | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | a year ago |
Adaptive Biotechnologies CorpADPT | 1 | Strong Buy | $30.00 | N/A | Maintains | 2 years ago |
Natera IncNTRA | 4 | Strong Buy | $155.00 | N/A | Maintains | 2 years ago |
Oncocyte CorpOCX | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | 3 years ago |
Chembio Diagnostics IncCEMI | 1 | Strong Buy | $12.00 | N/A | Maintains | 3 years ago |
Laboratory Corp Of America HoldingsLH | 4 | Hold | $155.00 | N/A | Maintains | 5 years ago |
Genmark Diagnostics IncGNMK | 4 | Strong Buy | $9.00 | N/A | Maintains | 5 years ago |
Quest Diagnostics IncDGX | 3 | Strong Buy | $105.00 | N/A | Maintains | 5 years ago |
Hologic IncHOLX | 3 | Hold | $41.00 | N/A | Maintains | 5 years ago |
Quidelortho CorpQDEL | 4 | Strong Buy | $80.00 | N/A | Maintains | 5 years ago |
Genomic Health IncGHDX | 3 | Strong Buy | $62.00 | N/A | Maintains | 5 years ago |
Illumina IncILMN | 3 | Strong Buy | $340.00 | N/A | Maintains | 5 years ago |
Heska CorpHSKA | 2 | Strong Buy | $123.00 | N/A | Maintains | 5 years ago |
Htg Molecular Diagnostics IncHTGMQ | 2 | Strong Buy | $1,260.00 | N/A | Maintains | 5 years ago |
Abaxis IncABAX | 1 | Hold | $47.00 | N/A | Maintains | 6 years ago |
Alere IncALR1 | 4 | Hold | $56.00 | N/A | Downgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.